These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 15823382

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.
    Burton MJ, Holland MJ, Makalo P, Aryee EA, Sillah A, Cohuet S, Natividad A, Alexander ND, Mabey DC, Bailey RL.
    PLoS Negl Trop Dis; 2010 Oct 05; 4(10):. PubMed ID: 20957147
    [Abstract] [Full Text] [Related]

  • 3. Impact of a single round of mass drug administration with azithromycin on active trachoma and ocular Chlamydia trachomatis prevalence and circulating strains in The Gambia and Senegal.
    Harding-Esch EM, Holland MJ, Schémann JF, Sillah A, Sarr B, Christerson L, Pickering H, Molina-Gonzalez S, Sarr I, Andreasen AA, Jeffries D, Grundy C, Mabey DCW, Herrmann B, Bailey RL.
    Parasit Vectors; 2019 Oct 22; 12(1):497. PubMed ID: 31640755
    [Abstract] [Full Text] [Related]

  • 4. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study.
    West SK, Munoz B, Mkocha H, Holland MJ, Aguirre A, Solomon AW, Foster A, Bailey RL, Mabey DC.
    Lancet; 2005 Oct 08; 366(9493):1296-300. PubMed ID: 16214600
    [Abstract] [Full Text] [Related]

  • 5. Mass treatment with single-dose azithromycin for trachoma.
    Solomon AW, Holland MJ, Alexander ND, Massae PA, Aguirre A, Natividad-Sancho A, Molina S, Safari S, Shao JF, Courtright P, Peeling RW, West SK, Bailey RL, Foster A, Mabey DC.
    N Engl J Med; 2004 Nov 04; 351(19):1962-71. PubMed ID: 15525721
    [Abstract] [Full Text] [Related]

  • 6. Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages.
    Burton MJ, Holland MJ, Faal N, Aryee EA, Alexander ND, Bah M, Faal H, West SK, Foster A, Johnson GJ, Mabey DC, Bailey RL.
    Invest Ophthalmol Vis Sci; 2003 Oct 04; 44(10):4215-22. PubMed ID: 14507864
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village.
    West SK, Munoz B, Mkocha H, Gaydos C, Quinn T.
    Invest Ophthalmol Vis Sci; 2007 Apr 04; 48(4):1492-7. PubMed ID: 17389476
    [Abstract] [Full Text] [Related]

  • 9. A rationale for continuing mass antibiotic distributions for trachoma.
    Ray KJ, Porco TC, Hong KC, Lee DC, Alemayehu W, Melese M, Lakew T, Yi E, House J, Chidambaram JD, Whitcher JP, Gaynor BD, Lietman TM.
    BMC Infect Dis; 2007 Aug 07; 7():91. PubMed ID: 17683646
    [Abstract] [Full Text] [Related]

  • 10. Randomised controlled trial of single-dose azithromycin in treatment of trachoma.
    Bailey RL, Arullendran P, Whittle HC, Mabey DC.
    Lancet; 1993 Aug 21; 342(8869):453-6. PubMed ID: 8102427
    [Abstract] [Full Text] [Related]

  • 11. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
    Biebesheimer JB, House J, Hong KC, Lakew T, Alemayehu W, Zhou Z, Moncada J, Rogér A, Keenan J, Gaynor BD, Schachter J, Lietman TM.
    Ophthalmology; 2009 Nov 21; 116(11):2047-50. PubMed ID: 19744717
    [Abstract] [Full Text] [Related]

  • 12. Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community.
    Ramadhani AM, Derrick T, Macleod D, Massae P, Malisa A, Mbuya K, Mtuy T, Makupa W, Roberts CH, Bailey RL, Mabey DCW, Holland MJ, Burton MJ.
    PLoS Negl Trop Dis; 2019 Jul 21; 13(7):e0007559. PubMed ID: 31306419
    [Abstract] [Full Text] [Related]

  • 13. Number of years of annual mass treatment with azithromycin needed to control trachoma in hyper-endemic communities in Tanzania.
    West SK, Munoz B, Mkocha H, Gaydos CA, Quinn TC.
    J Infect Dis; 2011 Jul 15; 204(2):268-73. PubMed ID: 21673038
    [Abstract] [Full Text] [Related]

  • 14. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
    Keenan JD, Tadesse Z, Gebresillasie S, Shiferaw A, Zerihun M, Emerson PM, Callahan K, Cotter SY, Stoller NE, Porco TC, Oldenburg CE, Lietman TM.
    PLoS Med; 2018 Aug 15; 15(8):e1002633. PubMed ID: 30106956
    [Abstract] [Full Text] [Related]

  • 15. The impact of a single round of community mass treatment with azithromycin on disease severity and ocular Chlamydia trachomatis load in treatment-naïve trachoma-endemic island communities in West Africa.
    Last AR, Burr SE, Harding-Esch E, Cassama E, Nabicassa M, Roberts CH, Mabey DCW, Holland MJ, Bailey RL.
    Parasit Vectors; 2017 Dec 28; 10(1):624. PubMed ID: 29282126
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Frequency of Mass Azithromycin Distribution for Ocular Chlamydia in a Trachoma Endemic Region of Ethiopia: A Cluster Randomized Trial.
    Lietman TM, Ayele B, Gebre T, Zerihun M, Tadesse Z, Emerson PM, Nash SD, Porco TC, Keenan JD, Oldenburg CE.
    Am J Ophthalmol; 2020 Jun 28; 214():143-150. PubMed ID: 32171768
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.